Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
98.21
-1.29 (-1.30%)
Oct 23, 2026, 11:29 AM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
25,99724,53816,49414,01410,00814,112
Market Cap Growth
-6.63%48.77%17.70%40.02%-29.08%-9.11%
Enterprise Value
24,34023,57815,21312,6589,44313,028
Last Close Price
99.5092.7062.3152.9441.7058.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
53.7835.5135.5135.5135.51-
PS Ratio
16.0630.2830.9536.2633.1174.13
PB Ratio
15.3122.7113.178.5212.7111.26
P/TBV Ratio
15.5323.3713.708.9614.9813.07
P/OCF Ratio
33.06-431.73---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.0529.0928.5432.7631.2468.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.471.050.830.540.700.18
Net Debt / Equity Ratio
-0.96-0.83-0.92-0.83-0.63-0.78
Net Debt / EBITDA Ratio
-3.344.476.653.821.032.11
Net Debt / FCF Ratio
-2.574.2720.094.601.091.86
Asset Turnover
0.500.270.180.170.180.10
Inventory Turnover
0.610.460.260.300.370.19
Quick Ratio
2.261.541.712.081.573.35
Current Ratio
2.501.711.882.221.773.69
Return on Equity (ROE)
38.00%-14.16%-10.37%-24.27%-47.59%-31.38%
Return on Assets (ROA)
8.80%-5.08%-4.60%-10.91%-19.70%-17.02%
Return on Capital Employed (ROCE)
19.60%-15.80%-13.30%-22.70%-57.30%-37.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.11%-0.66%-0.84%-1.99%-4.57%-3.20%
FCF Yield
2.45%-0.86%-0.35%-2.11%-4.59%-3.72%
Buyback Yield / Dilution
-1.16%0.85%-3.71%-6.74%0.19%-2.20%